So, the natural question for Vir Biotechnology (NASDAQ:VIR) shareholders is whether they should be concerned by its rate of cash burn. In this article, we define cash burn as its annual (negative) ...

After decades of failed attempts by corporate giants and research consortia across the globe, Kraig Biocraft Laboratories (OTCQB: KBLB) appears poised to crack biotechnology's most persistent ...

Biotechnology comprises the study and manipulation of living organisms with the goal of creating new products and processes that can improve our health and/or standards of living. It’s a field that ...

The biotechnology industry presents a high-stakes investment landscape, where outcomes for investors are often binary and the line between success and failure is remarkably thin. In the best-case ...

That starts with leadership from our policymakers. They must protect the foundation of all progress: federal support for ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Sana will present at Citi’s 2025 Global Healthcare Conference at 2:30 p.m. ET on Tuesday, December 2, 2025. Sana will present at the 8 th Annual Evercore Healthcare Conference at 2:35 p.m. ET on ...

In short, sickness and health don’t follow the stock market, so people will always need medical services and equipment regardless of what’s happening in the economy. This is why these industries are ...